MAGMITT Side Effects

6017799-3 | Impaired Gastric Emptying, Renal Cancer, Ventricular Tachycardia
on Dec 12, 2008 Male patient from JAPAN , weighting 123.5 lb, was diagnosed with chest discomfort and was treated with Magmitt (View Usage). Patient experienced the following unwanted or unexpected effects: impaired gastric emptying, renal cancer, ventricular tachycardia. Magmitt dosage: . During the same period patient was treated with WARFARIN SODIUM (1 Mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (25 Mcg) (View Thyradin S Review and Thyradin S Label ), RABEPRAZOLE SODIUM (10 Mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BULKOSE (View Bulkose Review and Bulkose Label ), SPIRIVA (18 Mcg) (View Spiriva Review and Spiriva Label ), FLUTIDE (View Flutide Review and Flutide Label ), SEREVENT (View Serevent Review and Serevent Label ).

5893709-4 | Renal Cancer, Ventricular Tachycardia
Patient was taking Magmitt (View Usage). Patient had the following side effects: renal cancer, ventricular tachycardia on Sep 11, 2008 from JAPAN Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with chest discomfort and. Magmitt dosage: . During the same period patient was treated with WARFARIN SODIUM (1 Mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), LEVOTHYROXINE SODIUM (25 Mcg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), RABEPRAZOLE SODIUM (10 Mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BULKOSE (View Bulkose Review and Bulkose Label ), SPIRIVA (18 Mcg) (View Spiriva Review and Spiriva Label ), FLUTIDE (View Flutide Review and Flutide Label ), SEREVENT (View Serevent Review and Serevent Label ).

5865818-7 | Interstitial Lung Disease, Neuropathy Peripheral
Adverse event was reported on Aug 21, 2008 by a Male patient taking Magmitt (View Usage) (Dosage: ) was diagnosed with constipation (What is constipation?), nausea (What is nausea?), cough, stomatitis, gastritis prophylaxis and. Location: JAPAN , 67 years of age, weighting 112.4 lb, After Magmitt was administered, patient had the following side effects: interstitial lung disease, neuropathy peripheral. During the same period patient was treated with SEROTONE (View Serotone Review and Serotone Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), HOKUNALIN: TAPE (View Hokunalin: Tape Review and Hokunalin: Tape Label ), CLEANAL (View Cleanal Review and Cleanal Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), NAUZELIN (View Nauzelin Review and Nauzelin Label ), AFTACH (Unk) (View Aftach Review and Aftach Label ), SELBEX (View Selbex Review and Selbex Label ).

5848641-9 | Duodenal Perforation, Peritonitis
on Aug 08, 2008 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with constipation (What is constipation?), malaise, peptic ulcer (What is peptic ulcer?), hyperuricaemia, hyperlipidaemia, polyuria, nausea (What is nausea?) and was treated with Magmitt (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal perforation, peritonitis. Magmitt dosage: . During the same period patient was treated with BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), GASTER D (View Gaster D Review and Gaster D Label ), URINORM (View Urinorm Review and Urinorm Label ), BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label ), LASIX (View Lasix Review and Lasix Label ), KYTRIL (View Kytril Review and Kytril Label ).


5746858-5 | Metabolic Acidosis
on May 14, 2008 Male patient from JAPAN , weighting 102.5 lb, was diagnosed with hypertension, cerebral ischaemia and was treated with Magmitt (View Usage). Patient had the following side effects: metabolic acidosis. Magmitt dosage: 990 Unk. During the same period patient was treated with RENAGEL (750 Mg) (View Renagel Review and Renagel Label ), PERINDOPRIL ERBUMINE (8 Mg) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), NORVASC (10 Mg) (View Norvasc Review and Norvasc Label ), DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), ADALAT (40 Mg) (View Adalat Review and Adalat Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5645409-3 | Metabolic Acidosis
Patient was taking Magmitt (View Usage). After Magmitt was administered, patient had the following side effects: metabolic acidosis on Feb 21, 2008 from JAPAN Additional patient health information: Male patient , weighting 102.5 lb, was diagnosed with hypertension, cerebral ischaemia and. Magmitt dosage: 990 Unk. During the same period patient was treated with RENAGEL (750 Mg) (View Renagel Review and Renagel Label ), COVERSYL (8 Mg) (View Coversyl Review and Coversyl Label ), NORVASC (10 Mg) (View Norvasc Review and Norvasc Label ), DIOVAN (80 Mg) (View Diovan Review and Diovan Label ), ADALAT (40 Mg) (View Adalat Review and Adalat Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

5349335-9 | Hepatic Function Abnormal
Adverse event was reported on May 28, 2007 by a Male patient taking Magmitt (View Usage) (Dosage: 1800 Mg) was diagnosed with cerebrovascular disorder and. Location: JAPAN , weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. During the same period patient was treated with GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ), ALEVIATIN (200 Mg) (View Aleviatin Review and Aleviatin Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5304822-4 | Hepatic Function Abnormal
on Apr 17, 2007 Male patient from JAPAN , weighting 145.5 lb, was diagnosed with cerebrovascular disorder and was treated with Magmitt (View Usage). Patient had the following side effects: hepatic function abnormal. Magmitt dosage: 1800 Mg. During the same period patient was treated with GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ), ALEVIATIN (200 Mg) (View Aleviatin Review and Aleviatin Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5295123-1 | Hepatic Function Abnormal
on Apr 03, 2007 Male patient from JAPAN , weighting 145.5 lb, was diagnosed with cerebrovascular disorder and was treated with Magmitt (View Usage). After Magmitt was administered, patient had the following side effects: hepatic function abnormal. Magmitt dosage: 1800 Mg. During the same period patient was treated with GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ), ALEVIATIN (200 Mg) (View Aleviatin Review and Aleviatin Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5128902-1 | Cough, Dysphagia, Granulocytopenia, Pneumonia, Pyrexia, White Blood Cell Count Decreased
Patient was taking Magmitt (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dysphagia, granulocytopenia, pneumonia (What is pneumonia?), pyrexia, white blood cell count decreased on Oct 05, 2006 from JAPAN Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with ill-defined disorder, hypertension and. Magmitt dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 4 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.